On Sunday, April 20th 2025, starting 8:30am GMT, there will be maintenance work that will involve the website being unavailable during parts of the day. We apologize for any inconvenience this may cause and appreciate your understanding.
We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Discovering HIV & AIDS genetic variants
- Heterogeneity in the HIV epidemic
- Natural history of HIV
- Candidate gene association studies
- Genotype-phenotype associations
- Genetic models
- CCR5 is a co-receptor for primary isolates of HIV
- HIV cell entry
- Consequence of Δ32 on the CCR5 protein
- CCR5 Δ32 allele and genotype frequencies
- CCR5 Δ32 homozygous individuals
- CCR5 ∆32 effect on progression to AIDS
- Trajectory of CD4 loss over time
- Summary (CCR5 ∆32)
- Bench to bedside translation
- HIV-1 life cycle: chemokine-receptor nexus
- HIV life cycle and points of restriction (1)
- PPIA promoter SNP
- HIV life cycle and points of restriction (2)
- Effects of post-entry factors on progression
- Summary (other factors)
- Immune surveillance for viral pathogens
- HLA gene classes
- HLA-B27 protects against HIV progression
- HLA candidate gene associations
- Host & viruses evolving arms race
- KIR regulate NK cell activity
- KIR genes
- Epistatic effect of KIR3DS1 & HLA-Bw4-80I
- KIRxHLA interaction effect on AIDS-free survival
- Genome wide association study (GWAS) era
- GWAS success
- Whole genome-wide association study
- Quantile-quantile plot
- Manhattan plot
- GWAS publications
- First HIV GWAS
- Two SNPs determinants of viral set point
- CD4<350 or ART initiation association with time
- Increasing statistical power
- Controller study data
- Novel associations
- Controlling HIV level vs. maintaining CD4 level
- Long term non-progressors
- Non-HLA and CCR5/2 associations from GWAS
- HIV acquisition
- HIV-related conditions
- C22 and HIV-associated nephropathy
- APOL1 risk alleles and sleeping sickness
- Summary (GWAS)
- Summary (final)
- Future directions: a systems-based approach
- Acknowledgements and disclaimers
Topics Covered
- Overview of candidate gene association studies of HIV and AIDS
- Key role for genetic variants involved in cell entry and host defenses
- Homozygous CCR5 32 basepair deletion prevents HIV Infection
- Acquired Immunity: HLA Class 1 proteins
- Key mediators of HIV progression
- Innate Protection: HLA and KIRS interactions in HIV disease
- Overview of Genome Wide Association Studies (GWAS)
- Overwhelming influence of HLA class I on HIV Progression and control of HIV viral load
- Non-HLA genetic associations with extreme phenotypes
- No new variants identified that prevent HIV infection
- Discovery of chromosome 22 associations with HIV-associated nephropathy
- Future studies
- Epigenetic, proteomic, functional studies
- Potential role of rare variants
Links
Categories:
Therapeutic Areas:
Talk Citation
Winkler, C.A. (2013, August 19). Host genetic factors that limit HIV and AIDS [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 15, 2025, from https://doi.org/10.69645/SMMO6871.Export Citation (RIS)
Publication History
- Published on August 19, 2013
Financial Disclosures
- Dr. Cheryl A. Winkler has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.